JNJ-18038683

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNJ-18038683, covering 2014-08-06 to 2023-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients [Phase 2]

See pricing